...
首页> 外文期刊>Respiratory Research >Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma
【24h】

Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma

机译:在绵羊过敏性哮喘模型中,雾化的全氟醚和二氧化碳迅速扩张了狭窄的气道

获取原文
           

摘要

BackgroundThe low toxicity of perfluorocarbons (PFCs), their high affinity for respiratory gases and their compatibility with lung surfactant have made them useful candidates for treating respiratory diseases such as adult respiratory distress syndrome. We report results for treating acute allergic and non-allergic bronchoconstriction in sheep using S-1226 (a gas mixture containing carbon dioxide and small volumes of nebulized perflubron). The carbon dioxide, which is highly soluble in perflubron, was used to relax airway smooth muscle.MethodsSheep previously sensitized to house dust mite (HDM) were challenged with HDM aerosols to induce early asthmatic responses. At the maximal responses (characterised by an increase in lung resistance), the sheep were either not treated or treated with one of the following; nebulized S-1226 (perflubron?+?12% CO2), nebulized perflubron?+?medical air, 12% CO2, salbutamol or medical air. Lung resistance was monitored for up to 20?minutes after cessation of treatment.In additional na?ve sheep, a segmental bronchus was pre-contracted with methacholine (MCh) and treated with nebulized S-1226 administered via a bronchoscope catheter. Subsequent bronchodilatation was monitored by real time digital video recording.ResultsTreatment with S-1226 for 2?minutes following HDM challenge resulted in a more rapid, more profound and more prolonged decline in lung resistance compared with the other treatment interventions. Video bronchoscopy showed an immediate and complete (within 5?seconds) re-opening of MCh-constricted airways following treatment with S-1226.ConclusionsS-1226 is a potent and rapid formulation for re-opening constricted airways. Its mechanism(s) of action are unknown. The formulation has potential as a rescue treatment for acute severe asthma.Electronic supplementary materialThe online version of this article (doi:10.1186/s12931-014-0098-x) contains supplementary material, which is available to authorized users.
机译:背景全氟化碳(PFC)的低毒性,对呼吸气体的高亲和力以及与肺表面活性剂的相容性,使其成为治疗呼吸系统疾病(例如成人呼吸窘迫综合征)的有用候选药物。我们报告了使用S-1226(含有二氧化碳和少量雾化全氟醚的气体混合物)治疗绵羊急性过敏性和非过敏性支气管狭窄的结果。二氧化碳是一种高度易溶于全氟醚的物质,用于松弛气道平滑肌。方法以前对屋尘螨(HDM)敏感的绵羊受到HDM气溶胶的刺激,引起早期哮喘反应。在最大反应(以肺阻力增加为特征)下,未对绵羊进行处理或采用以下方法之一进行处理:雾化的S-1226(全氟硼酸+ 12%的二氧化碳),全雾化的氟苯仑++医用空气,12%的二氧化碳,沙丁胺醇或医用空气。在停止治疗后长达20分钟监测肺阻力。在另外的幼稚羊中,将节段性支气管预先用乙酰甲胆碱(MCh)收缩,并用经支气管镜导管给药的雾化S-1226处理。结果通过HDM攻击后用S-1226治疗2分钟,与其他治疗干预相比,肺阻力下降更快,更深刻,更长期,这是通过实时数字视频记录来监测的。视频支气管镜检查显示,经S-1226处理后,MCH狭窄的气道可立即完全打开(5秒之内)。结论S-1226是有效且快速的重新狭窄气道的制剂。其作用机理未知。该制剂有可能作为急性重症哮喘的急救药物。电子补充材料本文的在线版本(doi:10.1186 / s12931-014-0098-x)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号